Bruce Gil
Bruce Gil is a journalist who has been covering the tech industry for Quartz since June 2024. He focuses on topics such as mergers and acquisitions, energy consolidation, and pharmaceutical developments. Prior to joining Quartz, Bruce worked at several other news outlets where he reported on various subjects including finance, healthcare, and politics.
Biography:
https://qz.com/author/brucegil
63%
The Daily's Verdict
This author has a mixed reputation for journalistic standards. It is advisable to fact-check, scrutinize for bias, and check for conflicts of interest before relying on the author's reporting.
Bias
86%
Examples:
- Novo Nordisk mentions its acquisition of three facilities for $11 billion and how it will increase production capacity from 2026 onwards. The author does not disclose any information about their connection to Novo Nordisk.
- The author uses sensationalism in some instances, such as stating that an artificial pancreas system will improve medical care and quality of life without providing evidence to support these claims.
- The author uses the word 'obese' instead of more neutral terms such as 'overweight'
Conflicts of Interest
50%
Examples:
- The author does not disclose any information about their connection to Novo Nordisk.
Contradictions
91%
Examples:
- The article quotes Travis Stice, chairman and CEO of Diamondback stating that this merger creates a 'must own North American independent oil company'. However, the author does not provide any evidence or data to support this claim.
- The article states that Ozempic can treat Type 1 diabetes when the FDA has not approved its use for this condition.
- The title suggests that Wegovy will now be covered for weight loss purposes when it has been approved by FDA for reducing heart risks.
Deceptions
46%
Examples:
- The article states that Diamondback Energy is set to acquire Endeavor Energy Resources in a stock-and-cash deal valued at $26 billion. However, it does not disclose any information about the financial health or performance of either company before or after the merger.
- The article states that Diamondback Energy will produce 816,000 barrels of oil and gas a day if West Texas Intermediate hits under $40 a barrel. However, this statement is misleading because it implies that the company's production will be profitable at such low prices when in reality, even with WTI at $77 per barrel they are still producing enough to break even.
- The author uses sensationalism by stating that an artificial pancreas system will improve medical care and quality of life without providing any evidence to support these claims.
Recent Articles
Novo Nordisk's Diabetes and Weight Loss Drugs: $600 a Month in the US, $59 in Germany - CEO to Testify Before Senate Committee
Broke On: Monday, 17 June 2024Novo Nordisk, Europe's most valuable company in 2023, faces scrutiny over price discrepancies of diabetes drugs Ozempic and Wegovy in the US. The CEO will testify before the Senate HELP committee regarding these high prices, which are significantly lower in other countries. A study found that Ozempic costs $541 less per month in Germany, while Wegovy costs $727 less in the UK. Critics argue that justifications for these price disparities do not excuse such significant differences. 
Moderna in Talks with US Government for Funding of Potential Bird Flu Vaccine, mRNA-1018
Broke On: Tuesday, 28 May 2024Moderna is in talks with the U.S. government for potential funding and a purchase commitment for its mRNA H5N1 bird flu vaccine, mRNA-1018, following confirmation of human cases in the US. The rapid spread of H5N1 among poultry and cattle necessitates quick production through mRNA technology, with Moderna expecting data soon from early-stage trials. Moderna in Talks with US Government for Funding of Potential Bird Flu Vaccine, mRNA-1018
Broke On: Tuesday, 28 May 2024Moderna is in talks with the U.S. government for potential funding and a purchase commitment for its mRNA H5N1 bird flu vaccine, mRNA-1018, following confirmation of human cases in the US. The rapid spread of H5N1 among poultry and cattle necessitates quick production through mRNA technology, with Moderna expecting data soon from early-stage trials. 
New FAA Rest Requirements for Air Traffic Controllers: 10 Hours Off Between Shifts and 12 Hours Before Midnight Shift
Broke On: Friday, 19 April 2024The FAA implements new rest requirements for air traffic controllers, mandating a minimum of 10 hours off between shifts and 12 hours off before midnight shifts, in response to concerns over fatigue and safety issues. The changes aim to address risks associated with controller fatigue and reverse decades-long staff shortages. Hiring 1,800 new controllers this year is part of the FAA's efforts to improve working conditions and prioritize controller safety. 
WHO Updates Terminology: Pathogens That Transmit Through the Air - COVID-19, Influenza, and More
Broke On: Thursday, 18 April 2024The World Health Organization (WHO) has updated the terminology for airborne viruses, including COVID-19, to be called 'pathogens that transmit through the air.' The WHO now discourages differentiating between aerosols and larger droplets and emphasizes they exist on a continuous spectrum of sizes. This update aims to eliminate confusion in communicating virus transmission among human populations following discrepancies during the COVID-19 pandemic response. 
Revolutionizing Type 1 Diabetes: The NHS Rolls Out Artificial Pancreas System
Broke On: Thursday, 04 April 2024The NHS in England is set to roll out an artificial pancreas system, also known as a closed loop system, to people with Type 1 diabetes. The hybrid closed loop system will continually monitor a person's blood glucose levels and automatically adjust the amount of insulin given through a pump. This technology holds the power to redefine the lives of those with Type 1 diabetes by promising better quality of life as well as clinical outcomes. 
Wegovy Now Covered Under Medicare Part D for Heart Health in Obese and Overweight Adults
Broke On: Thursday, 21 March 2024Medicare Part D covers Wegovy, a weight loss drug that reduces heart risks for obese or overweight adults. The FDA approved it in March after a clinical trial showed 20% reduction in serious heart events. 
Diamondback Energy and Endeavor Energy Resources Announce $26 Billion Merger in Permian Basin Oil and Gas Industry
Broke On: Monday, 12 February 2024The Permian Basin, straddling New Mexico and Texas, is the most productive oil and gas field in the US. Diamondback Energy generates $9.6 billion in revenue from oil while Endeavor Energy Resources based out of Midland joins forces with Diamondback through a $26 billion merger deal. 
Snap Inc. Announces 10% Global Workforce Layoffs, Costing Between $55 Million and $75 Million in Pre-Tax Charges
Broke On: Monday, 05 February 2024Snap Inc., the parent company of Snapchat, announced it will lay off 10% of its global workforce in Q1 2024. Approximately 540 employees will lose their jobs and the cost is estimated to be between $55 million and $75 million in pre-tax charges.